MedTrace Logo

Genetic Markers of Diabetic Ulcers and Personalized Treatment Targets Research

NCT06979037 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 712

Last updated 2025-05-18

No results posted yet for this study

Summary

This clinical trial involves collecting peripheral blood, ulcer tissue, and fecal samples from diabetic ulcer patients for bioinformatics analysis to screen genetic markers significantly associated with ulcer risk and healing differences. Furthermore, multi-omics data will be integrated to establish a diabetic ulcer risk prediction model. Based on key single nucleotide polymorphisms and their regulatory pathways, potential new drug targets for promoting healing will be explored, providing a genetic basis for personalized treatment.

Conditions

  • Diabetic Ulcers

Sponsors & Collaborators

  • The First Affiliated Hospital of University of South China

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-16
Primary Completion
2027-05-16
Completion
2027-05-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06979037 on ClinicalTrials.gov